Related Experiment Videos

Peroxidase activity in peritoneal macrophages of patients with terminal renal failure treated by intermittent

W Sułowicz1, R Pawlicki, Z Hanicki

  • 1Department of Nephrology, Medical Academy, Kraków, Poland.

Nephron
|January 1, 1990
PubMed

Insights

Patients undergoing peritoneal dialysis (PD) exhibit elevated macrophage peroxidase activity. This activity decreases during peritonitis, a common PD complication, but remains higher than in healthy individuals.

Area of Science:

  • Immunology
  • Nephrology
  • Cell Biology

Background:

  • Peritoneal dialysis (PD) is a treatment for end-stage renal failure.
  • Macrophages play a role in the inflammatory response during PD and its complications.
  • Peroxidase activity in macrophages is an indicator of cellular activity.

Purpose of the Study:

  • To assess peroxidase activity in macrophages of patients undergoing PD.
  • To compare peroxidase activity in patients with and without peritonitis.
  • To investigate the cellular localization of peroxidase in these macrophages.

Main Methods:

  • Cytochemical assessment of peroxidase activity in macrophages from peritoneal dialysate.
  • Semiquantitative score test for peroxidase activity.
  • Electron-microscopic cytochemistry for subcellular localization.

Main Results:

  • Macrophages from PD patients showed significantly higher peroxidase activity compared to controls.
  • Peroxidase activity was significantly lower during peritonitis compared to the complication-free period in PD patients.
  • Electron microscopy confirmed peroxidase activity localized to cytoplasmic granules in all groups.

Conclusions:

  • PD treatment is associated with enhanced macrophage peroxidase activity.
  • Peritonitis leads to a decrease in macrophage peroxidase activity during PD.
  • The studied macrophages share characteristics with exudative macrophages.

Related Concept Videos